Diabetes Research and Clinical Practice
Volume 87, Issue 1 , Pages 126-131, January 2010

Hemoglobin A1c in predicting progression to diabetes

  • Tomoko Nakagami

      Affiliations

    • Diabetes Centre, Tokyo Women's Medical University, 8-1, Kawada-cho, Shinjuku-ku Tokyo 162-8666, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 3 3353 8111; fax: +81 3 3358 1941.
  • ,
  • Naoko Tajima

      Affiliations

    • Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan
  • ,
  • Toshihide Oizumi

      Affiliations

    • Third Department of Internal Medicine, Yamagata University School of Medicine, Yamagata, Japan
  • ,
  • Shigeru Karasawa

      Affiliations

    • Third Department of Internal Medicine, Yamagata University School of Medicine, Yamagata, Japan
  • ,
  • Kiriko Wada

      Affiliations

    • Third Department of Internal Medicine, Yamagata University School of Medicine, Yamagata, Japan
  • ,
  • Wataru Kameda

      Affiliations

    • Third Department of Internal Medicine, Yamagata University School of Medicine, Yamagata, Japan
  • ,
  • Shinji Susa

      Affiliations

    • Third Department of Internal Medicine, Yamagata University School of Medicine, Yamagata, Japan
  • ,
  • Takeo Kato

      Affiliations

    • Third Department of Internal Medicine, Yamagata University School of Medicine, Yamagata, Japan
  • ,
  • Makoto Daimon

      Affiliations

    • Third Department of Internal Medicine, Yamagata University School of Medicine, Yamagata, Japan

Received 18 June 2009; received in revised form 27 October 2009; accepted 2 November 2009. published online 30 November 2009.

Abstract 

The predictive value of hemoglobin A1c (HbA1c) in comparison to fasting plasma glucose (FPG) is evaluated for 5-year incident diabetes (DM), as HbA1c may be more practical than FPG in the screening for DM in the future. Of 1189 non-DM subjects aged 35–89 years old from the Funagata Study, 57 subjects (4.8%) had developed DM on the WHO criteria at 5-year follow-up. The odds ratio (95% confidence interval: CI) for a one standard deviation increase in FPG/HbA1c was 3.40 (2.44–4.74)/3.49 (2.42–5.02). The area under the receiver operating characteristic curve for FPG/HbA1c was 0.786 (95% CI: 0.719–0.853)/0.785 (0.714–0.855). The HbA1c corresponding to FPG 5.56mmol/l was HbA1c 5.3%. There was no statistical difference in sensitivity between FPG 5.56mmol/l and HbA1c 5.3% (61.4% vs. 56.1%), while specificity was higher in HbA1c 5.3% than FPG 5.56mmol/l (87.8% vs. 82.5%, p-value<0.001). The fraction of incident case from those with baseline IGT was similar between the groups, however the fraction of people above the cut-off was significantly lower in HbA1c 5.3% than FPG 5.56mmol/l (14.3% vs. 19.6%, p-value<0.001). HbA1c is similar to FPG to evaluate DM risk, and HbA1c could be practical and efficient to select subjects for intervention.

Abbreviations: ADA, American Diabetes Association, CI, confidence intervals, BMI, body mass index, DM, diabetes mellitus, FPG, fasting plasma glucose, HbA1c, hemoglobin A1c, IGT, impaired glucose tolerance, JDS, Japan Diabetes Society, OGTT, oral glucose tolerance test, OR, odds ratio, ROC, receiver operating characteristic, Wc, Waist circumference, WHO, World Health Organization, 2h PG, 2h plasma glucose

Keywords: Diabetes mellitus, Fasting plasma glucose, Hemoglobin A1c, Incidence, Impaired glucose tolerance

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Research grant: Japanese Ministry of Health, Labour and Warfare, Some results of this paper were presented at the 43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam, The Netherlands in September 2007.

PII: S0168-8227(09)00472-0

doi:10.1016/j.diabres.2009.11.001

Diabetes Research and Clinical Practice
Volume 87, Issue 1 , Pages 126-131, January 2010